Neuroendocrine tumor trang 1 tải miễn phí từ TAILIEUCHUNG

"Neuroendocrine tumor" trang 1 - tải miễn phí từ Tailieuchung

Clinicopathological analysis in patients with neuroendocrine tumors that metastasized to the brain

Clinicopathological analysis in patients with neuroendocrine tumors that metastasized to the brain

8 61 1

Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors

Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors

9 30 1

BREAST CANCER – FOCUSING TUMOR MICROENVIRONMENT, STEM CELLS AND METASTASIS

BREAST CANCER – FOCUSING TUMOR MICROENVIRONMENT, STEM CELLS AND METASTASIS

594 58 0

NEUROENDOCRINE TUMOR

NEUROENDOCRINE TUMOR

70 72 0

Treatment with somatostatin analogs induces differentially expressed let-7c-5p and mir-3137 in small intestine neuroendocrine tumors

Treatment with somatostatin analogs induces differentially expressed let-7c-5p and mir-3137 in small intestine neuroendocrine tumors

8 56 0

Brain metastases in patients with neuroendocrine neoplasms: Risk factors and outcome

Brain metastases in patients with neuroendocrine neoplasms: Risk factors and outcome

9 36 0

Neuroendocrine Tumor Edited by Anthony Lowell

Neuroendocrine Tumor Edited by Anthony Lowell

70 80 0

Proinsulin-predominant pancreatic neuroendocrine tumor-induced hypoglycemia after Roux-En-Y gastric bypass surgery

Proinsulin-predominant pancreatic neuroendocrine tumor-induced hypoglycemia after Roux-En-Y gastric bypass surgery

5 48 0

The first pancreatic neuroendocrine tumor in Li-Fraumeni syndrome: A case report

The first pancreatic neuroendocrine tumor in Li-Fraumeni syndrome: A case report

6 94 0

Long-term outcomes following 90Y Radioembolization of neuroendocrine liver metastases: Evaluation of the radiation-emitting SIR-spheres in non-resectable liver tumor (RESiN) registry

Long-term outcomes following 90Y Radioembolization of neuroendocrine liver metastases: Evaluation of the radiation-emitting SIR-spheres in non-resectable liver tumor (RESiN) registry

11 9 1

Achieving objective response in treatment of non-resectable neuroendocrine tumors does not predict longer time to progression compared to achieving stable disease

Achieving objective response in treatment of non-resectable neuroendocrine tumors does not predict longer time to progression compared to achieving stable disease

7 60 0

Risk factors associated with the progression and metastases of hindgut neuroendocrine tumors: A retrospective study

Risk factors associated with the progression and metastases of hindgut neuroendocrine tumors: A retrospective study

7 67 1

Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection

Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection

9 39 1

Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?

Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?

10 64 1

Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors

Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors

7 20 1

Lung neuroendocrine tumors: correlation of ubiquitinylation and sumoylation with nucleo-cytosolic partitioning of PTEN

Lung neuroendocrine tumors: correlation of ubiquitinylation and sumoylation with nucleo-cytosolic partitioning of PTEN

10 21 1

The clinical features and treatment modality of esophageal neuroendocrine tumors: A multicenter study in Korea

The clinical features and treatment modality of esophageal neuroendocrine tumors: A multicenter study in Korea

7 23 1

Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: The xelbevoct study

Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: The xelbevoct study

10 24 1

Combination of carbonic anhydrase inhibitor, acetazolamide, and sulforaphane, reduces the viability and growth of bronchial carcinoid cell lines

Combination of carbonic anhydrase inhibitor, acetazolamide, and sulforaphane, reduces the viability and growth of bronchial carcinoid cell lines

18 34 1

Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization

Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization

13 38 1

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.